Power Law company profile

Ablynx

Biotech & Life Sciences · Ghent, Belgium · Founded 2001 · IPO 2007 Unicorn

Proprietary therapeutic proteins for treating life-threatening diseases

Valuation

$4.29B

Market cap · 2026

Revenue

$135M

Latest reported FY

EBITDA

$88M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

11 investors on Ablynx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Gimv

Sofinnova Partners

Gilde Healthcare

Series B+ 8 investors entered at this stage

KBC

Alta Partners

Vrije Universiteit Brussel

SR One

Alta Ventures

Abingworth

KBC

Flanders Institute for Biotechnology

Ablynx mafia

Startups founded by Ablynx alumni

Former Ablynx employees who went on to start their own companies. Sorted by Dealroom signal score.

argenxEst. 2008

Tim Van HauwermeirenBelgium

Signal score89

Confo TherapeuticsEst. 2015

Jan SteyaertBelgium

Signal score83

Curve TherapeuticsEst. 2019

SKSimon KerryUnited Kingdom

Signal score77

Ona TherapeuticsEst. 2019

VVValerie VanhoorenSpain

Legacy HealthcareEst. 2007

Geert CauwenberghSwitzerland

Signal score64

Book a demo to explore the full alumni network →

Global footprint

Where Ablynx has talent and traffic

Workforce by country

3 countries with
team presence

🇧🇪 Belgium97.5%

🇺🇸 United States1.2%

🇳🇱 Netherlands1.2%

3 countries shown

Web traffic by country

180 monthly visits
across markets

🇫🇷 France111.1%

Top 1 markets shown

Patent intelligence

$2B patent portfolio · 1,356 active families

Estimated portfolio value

$2B

47.3% of market cap · 2.6× the top peer BioNTech ($780M)

1,356 active patent families

Where Ablynx innovates Molecular biologyPharmaceutical drugDiseaseNucleic acidGlobulin

Where Ablynx concentrates vs peers

Each axis is a top-10 topic across Ablynx and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Ablynx

An AI-synthesized read of the highest-engagement posts about Ablynx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ablynx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles